FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns
Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA’s request for more phase 3 research “deeply disappointing.”
The Future Is Here
Source : https://gizmodo.com/fda-holds-back-mdma-psychedelic-therapy-over-safety-efficacy-concerns-2000485535